{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:15:16Z","timestamp":1790972116750,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.nucmedbio.2014.11.005","type":"journal-article","created":{"date-parts":[[2014,11,22]],"date-time":"2014-11-22T13:44:20Z","timestamp":1416663860000},"page":"360-368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["The impact of weakly bound 89Zr on preclinical studies: Non-specific accumulation in solid tumors and aspergillus infection"],"prefix":"10.1016","volume":"42","author":[{"given":"Gregory W.","family":"Severin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper T.","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Wiehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Maria","family":"Rolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders E.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Hasenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd","family":"Pichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kj\u00e6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas I.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0005","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2174\/1568026611313040005","article-title":"89Zr-PET radiochemistry in the development and application of therapeutic monoclonal antibodies and other biologicals","volume":"13","author":"Vugts","year":"2013","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0010","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.3390\/molecules18066469","article-title":"89Zr, a radiometal nuclide with high potential for molecular imaging with PET: chemistry, applications and remaining challenges","volume":"18","author":"Fischer","year":"2013","journal-title":"Molecules"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nucmedbio.2012.08.004","article-title":"PET imaging with 89Zr: From radiochemistry to the clinic","volume":"40","author":"Deri","year":"2013","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/1874471011104020131","article-title":"PET tracers based on zirconium-89","volume":"4","author":"Zhang","year":"2011","journal-title":"Curr Radiopharm"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0025","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2174\/157340611796799186","article-title":"89Zr radiochemistry for positron emission tomography","volume":"7","author":"Severin","year":"2011","journal-title":"Med Chem"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3390\/ph5010079","article-title":"89Zr-radiolabeled trastuzumab imaging in orthotopic and metastatic breast tumors","volume":"5","author":"Chang","year":"2012","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0035","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.2967\/jnumed.110.086520","article-title":"Imaging of prostate cancer with immuno-PET and immuno-SPECT using a radiolabeled anti-EGP-1 monoclonal antibody","volume":"52","author":"Van Rij","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0040","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.2967\/jnumed.110.076174","article-title":"89Zr-DFO-J591 for immunoPET of prostate-specific membrane antigen expression in vivo","volume":"51","author":"Holland","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0045","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.nucmedbio.2010.12.011","article-title":"In vivo biodistribution and accumulation of 89Zr in mice","volume":"38","author":"Abou","year":"2011","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0050","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0969-8051(96)00119-9","article-title":"The mechanism of 67Ga localization in malignant disease","volume":"23","author":"Weiner","year":"1996","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0055","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.nucmedbio.2013.01.002","article-title":"High tumor uptake of 64Cu: implications for molecular imaging of tumor characteristics with copper-based PET tracers","volume":"40","author":"J\u00f8rgensen","year":"2013","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0060","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/BF02349525","article-title":"Biochemical reactions of various trace elements with blood components and transport proteins","volume":"239","author":"Sotogaku","year":"1999","journal-title":"J Radioanal Nucl Chem"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0065","first-page":"5444","article-title":"Binding of transition metal ions to albumin: sites, affinities and rates","volume":"2013","author":"Bal","year":"1830","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0070","doi-asserted-by":"crossref","first-page":"625","DOI":"10.2967\/jnumed.110.083998","article-title":"Magnitude of enhanced permeability and retention effect in tumors with different phenotypes: 89Zr-albumin as a model system","volume":"52","author":"Heneweer","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0075","first-page":"6387","article-title":"A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent Smancs","volume":"46","author":"Matsumura","year":"1986","journal-title":"Cancer Res"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0080","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1371\/journal.ppat.0030128","article-title":"Distinct roles for intra- and extracellular siderophores during Aspergillus fumigatus infection","volume":"3","author":"Schrettl","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0085","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2967\/jnumed.109.072462","article-title":"68Ga-siderophores for PET imaging of invasive pulmonary aspergillosis: proof of principle","volume":"51","author":"Petrik","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0090","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00259-012-2110-3","article-title":"Preclinical evaluation of two 68Ga-siderophores as potential radiopharmaceuticals for Aspergillus fumigatus infection imaging","volume":"39","author":"Petrik","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0095","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3923\/pjbs.2010.1151.1155","article-title":"Production of desferrioxamine B (Desferal) using corn steep liquor in Streptomyces pilosus","volume":"13","author":"Chiani","year":"2010","journal-title":"Pak J Biol Sci"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0100","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.nucmedbio.2009.05.007","article-title":"Standardized methods for the production of high specific-activity zirconium-89","volume":"36","author":"Holland","year":"2009","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0105","doi-asserted-by":"crossref","first-page":"e1000873","DOI":"10.1371\/journal.ppat.1000873","article-title":"Production of extracellular traps against Aspergillus fumigatus in vitro and in infected lung tissue is dependent on invading neutrophils and influenced by hydrophobin RodA","volume":"6","author":"Bruns","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0110","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/18811248.2007.9711515","article-title":"Zirconium solubility in ternary aqueous system of Zr(IV)-OH-carboxylates","volume":"46","author":"Kobayashi","year":"2009","journal-title":"J Nucl Sci Technol"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0115","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1039\/C2CC37549D","article-title":"Investigation of Zr(IV) and 89Zr(IV) complexation with hydroxamates: Progress towards designing a better chelator than desferrioxamine B for immuno-PET imaging","volume":"49","author":"Gu\u00e9rard","year":"2013","journal-title":"Chem Commun"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0120","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/nm.2935","article-title":"Annotating MYC status with 89Zr-transferrin imaging","volume":"18","author":"Holland","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0125","first-page":"157","article-title":"Imaging of inflammation by PET, conventional scintigraphy, and other imaging techniques","volume":"41","author":"Gotthardt","year":"2013","journal-title":"J Nucl Med Technol"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0130","first-page":"683","article-title":"Preparation, biodistribution, and small animal PET of 45Ti-transferrin","volume":"46","author":"Vavere","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0135","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1021\/bm401871w","article-title":"Positron emission tomography based analysis of long-circulating cross-linked triblock polymeric micelles in a U87MG mouse xenograft model and comparison of DOTA and CB-TE2A as chelators of copper-64","volume":"15","author":"Jensen","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0140","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1016\/j.biomaterials.2010.11.059","article-title":"64Cu loaded liposomes as positron emission tomography imaging agents","volume":"32","author":"Petersen","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0145","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1007\/s11095-012-0929-8","article-title":"89Zr-labeled paramagnetic octreotide-liposomes for PET-MR imaging of cancer","volume":"30","author":"Abou","year":"2013","journal-title":"Pharm Res"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0150","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1054\/bjoc.1999.1232","article-title":"Biodistribution and pharmacokinetics of In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies","volume":"83","author":"Harrington","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0155","first-page":"243","article-title":"Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes","author":"Harrington","year":"2001","journal-title":"Clin Cancer Res"},{"issue":"Suppl. 1","key":"10.1016\/j.nucmedbio.2014.11.005_bb0160","first-page":"164S","article-title":"The promise of immuno-PET in radioimmunotherapy","volume":"46","author":"Verel","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2014.11.005_bb0165","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.2967\/jnumed.109.065862","article-title":"Radiation dosimetry of 89Zr-labeled chimeric monoclonal antibody U36 as used for immuno-PET in head and neck cancer patients","volume":"50","author":"B\u00f6rjesson","year":"2009","journal-title":"J Nucl Med"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805114005423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805114005423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T04:27:56Z","timestamp":1760848076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805114005423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0969805114005423"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2014.11.005","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of weakly bound 89Zr on preclinical studies: Non-specific accumulation in solid tumors and aspergillus infection","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2014.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}